The closing price of Wave Life Sciences Ltd. (NASDAQ: WVE) was $4.21 for the day, up 2.68% from the previous closing price of $4.10. In other words, the price has increased by $+0.1100 from its previous closing price. On the day, 494561 shares were traded. WVE stock price reached its highest trading level at $4.3500 during the session, while it also had its lowest trading level at $4.0850.
Our analysis of WVE’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 2.00.
Upgrades & Downgrades
On October 23, 2020, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $13.
SVB Leerink Downgraded its Outperform to Mkt Perform on December 31, 2019, whereas the target price for the stock was revised from $33 to $10.
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 16 when RA CAPITAL MANAGEMENT, L.P. bought 9,480,052 shares for $2.15 per share. The transaction valued at 20,382,112 led to the insider holds 17,202,009 shares of the business.
Vargeese Chandra sold 16,714 shares of WVE for $28,748 on May 05. The insider now owns 111,095 shares after completing the transaction at $1.72 per share. On May 05, another insider, Francis Chris, who serves as the insider of the company, sold 10,867 shares for $1.72 each. As a result, the insider received 18,691 and left with 89,972 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 81.87.
Stock Price History:
Over the past 52 weeks, WVE has reached a high of $5.31, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is 4.1190, while the 200-Day Moving Average is calculated to be 2.8958.
WVE traded an average of 322.18K shares per day over the past three months and 413.67k shares per day over the past ten days. A total of 93.90M shares are outstanding, with a floating share count of 72.78M. Insiders hold about 16.24% of the company’s shares, while institutions hold 78.60% stake in the company. Shares short for WVE as of Oct 13, 2022 were 1.58M with a Short Ratio of 1.45M, compared to 1.49M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.82% and a Short% of Float of 2.49%.
The firm’s stock currently is rated by 6 analysts. On average, analysts expect EPS of -$0.5 for the current quarter, with a high estimate of -$0.42 and a low estimate of -$0.62, while EPS last year was -$0.12. The consensus estimate for the next quarter is -$0.55, with high estimates of -$0.44 and low estimates of -$0.72.
Analysts are recommending an EPS of between -$2.04 and -$2.51 for the fiscal current year, implying an average EPS of -$2.27. EPS for the following year is -$1.67, with 6 analysts recommending between -$1.26 and -$2.32.
A total of 7 analysts have provided revenue estimates for WVE’s current fiscal year. The highest revenue estimate was $52M, while the lowest revenue estimate was $7.1M, resulting in an average revenue estimate of $16.64M. In the same quarter a year ago, actual revenue was $40.96M, down -59.40% from the average estimate.